Moreover, we attempted to develop a novel therapeutic strategy and identify a predictive biomarker for the prevention of DT cell emergence following ALK-TKI intervention, owing to the eradication of tumor activity in ALK-rearranged lung cancer. The gene discussed is ALK; the disease is neoplasm.